Inspire Medical Systems, Inc. Common Stock (INSP)
Frequently Asked Questions About Inspire Medical Systems, Inc. Common Stock (INSP)
How can patients get access to Inspire therapy?
Patients interested in Inspire therapy should first consult with their healthcare provider to assess their sleep apnea condition and determine if they are candidates for the procedure. If appropriate, the provider can refer the patient to a specialist trained in Inspire therapy for further evaluation and potential treatment options.
How is Inspire Medical Systems, Inc. regulated?
Inspire Medical Systems, Inc. is regulated by the U.S. Food and Drug Administration (FDA) and must comply with all applicable medical device laws and regulations. The Inspire therapy has received FDA approval, making it a viable treatment option in the United States for appropriate patients suffering from obstructive sleep apnea.
How many employees does Inspire Medical Systems, Inc. have?
As of the latest reports, Inspire Medical Systems, Inc. employs approximately 200 individuals. The company’s workforce includes professionals from various fields such as engineering, clinical research, marketing, and regulatory affairs, all focused on advancing its mission to improve treatment for obstructive sleep apnea.
Is Inspire Medical Systems involved in any partnerships?
Yes, Inspire Medical Systems collaborates with various entities, including healthcare providers, research institutions, and industry partners, to advance its technology and improve patient care in sleep medicine. These partnerships often focus on clinical research, education, and awareness initiatives aimed at enhancing the understanding and treatment of obstructive sleep apnea.
What are the potential risks associated with Inspire therapy?
As with any medical procedure, there are potential risks associated with Inspire therapy, including surgical complications, device malfunction, and infection. Patients must be thoroughly assessed to determine their suitability for the device, and they receive comprehensive information regarding potential risks and benefits prior to undergoing the procedure.
What distinguishes Inspire Medical Systems from its competitors?
Inspire Medical Systems distinguishes itself from competitors primarily through its pioneering Inspire therapy, which offers a unique, implantable solution targeting the root cause of obstructive sleep apnea. Unlike traditional CPAP devices, which rely on external airflow, the Inspire device provides a personalized therapy option, addressing the needs of patients who are non-compliant with CPAP or have not achieved adequate results with that therapy.
What does Inspire Medical Systems, Inc. do?
Inspire Medical Systems, Inc. specializes in the development and commercialization of innovative medical devices for the treatment of obstructive sleep apnea (OSA). Their flagship product is the Inspire therapy, a surgically implanted neurostimulation device that offers a new solution for patients who are unable to tolerate continuous positive airway pressure (CPAP) devices. By delivering mild electrical stimulation to the hypoglossal nerve during sleep, the Inspire device helps keep the airway open, significantly improving the quality of life for individuals suffering from OSA.
What is Inspire Medical Systems’ commitment to patient safety?
Inspire Medical Systems is deeply committed to patient safety and adheres to the highest standards of quality and regulatory compliance in the design, manufacturing, and monitoring of its devices. The company continuously collects patient data to assess long-term safety and efficacy while investing in ongoing training for healthcare providers to ensure the best care practices.
What is the company’s approach to innovation?
Inspire Medical Systems, Inc. is committed to continuous innovation in the field of sleep medicine. The company invests heavily in research and development to enhance its existing technologies and develop new solutions that can effectively address the challenges of obstructive sleep apnea and improve patient care.
What is the company’s financial performance like?
Inspire Medical Systems, Inc. has demonstrated consistent growth in financial performance, with increasing revenues driven by the growing adoption of its Inspire therapy among patients and healthcare providers. The company's quarterly earnings reports reflect positive trends and a solid financial outlook, contributing to investor confidence in its business model and long-term viability.
What is the company’s vision?
Inspire Medical Systems, Inc. envisions a world where every patient suffering from obstructive sleep apnea has access to effective treatment options that enhance their quality of life. The company's mission aligns with improving patient outcomes and providing an alternative to traditional therapy, ensuring a comprehensive approach to sleep apnea management.
What is the Inspire therapy?
The Inspire therapy is an implanted neurostimulation device designed for the treatment of obstructive sleep apnea. When activated, the device stimulates the hypoglossal nerve to prevent airway collapse during sleep. Patients undergo a surgical procedure to have the device implanted, which is then remotely controlled via a small handheld device to ensure optimal therapy.
What markets does Inspire Medical Systems operate in?
Inspire Medical Systems currently operates primarily in the United States but has begun to expand into international markets, particularly in Europe. As awareness of obstructive sleep apnea and the benefits of Inspire therapy grow, the company aims to reach more patients globally and address their needs through strategic market entry.
What support does Inspire Medical Systems offer to patients?
Inspire Medical Systems provides a robust support system for patients throughout their journey with Inspire therapy. This includes personalized education about the device, ongoing follow-up care, and access to a dedicated team of healthcare professionals who can assist with any questions or concerns about the therapy.
What types of clinical studies has Inspire Medical Systems conducted?
Inspire Medical Systems has conducted numerous clinical studies to evaluate the safety and efficacy of the Inspire therapy. These studies often involve patient participation and have shown significant improvements in sleep apnea symptoms, quality of life, and reductions in associated health risks. The results of these studies have been published in various medical journals, supporting the clinical use of their device.
When did Inspire Medical Systems, Inc. go public?
Inspire Medical Systems, Inc. went public on May 10, 2018, with an initial public offering (IPO) on the New York Stock Exchange under the ticker symbol INSP. The IPO was a significant milestone for the company as it provided additional capital to support ongoing product development and market expansion.
When was Inspire Medical Systems, Inc. founded?
Inspire Medical Systems, Inc. was founded in 2007. The company emerged from research conducted at the University of Minnesota and was established to address the unmet need in sleep apnea treatment, particularly for patients who do not benefit from traditional therapies such as CPAP machines.
Where is Inspire Medical Systems, Inc. located?
Inspire Medical Systems, Inc. is headquartered in Minneapolis, Minnesota. This location allows the company to leverage the region's strengths in medical technology and innovation, as well as to collaborate with research institutions and healthcare providers in the area.
Who can benefit from Inspire therapy?
Inspire therapy is aimed at adult patients with moderate to severe obstructive sleep apnea who are unable to achieve satisfactory results with CPAP therapy. Ideal candidates are typically those with a body mass index (BMI) of 32 or less, not significantly overweight, and with no other anatomical obstructions contributing to their apnea.
What is the current price of Inspire Medical Systems, Inc. Common Stock?
The current price of Inspire Medical Systems, Inc. Common Stock is 141.52
When was Inspire Medical Systems, Inc. Common Stock last traded?
The last trade of Inspire Medical Systems, Inc. Common Stock was at 2:54 pm EDT on April 4th, 2025
What is the market capitalization of Inspire Medical Systems, Inc. Common Stock?
The market capitalization of Inspire Medical Systems, Inc. Common Stock is 3.86B
How many shares of Inspire Medical Systems, Inc. Common Stock are outstanding?
Inspire Medical Systems, Inc. Common Stock has 27.27M shares outstanding.